ABSTRACT
Covid-19 infection has more relevant consequences in frail and comorbid patients but little is known about its course in patients with hematologic malignancies. In this report we would like to present the case of a patient with multiple myeloma treated with recent autologous bone marrow stem cell transplantation and affected by Covid-19 pneumonia, presenting with a possible reinfection or an extremely long viral shedding.Copyright © 2023 Tehran University of Medical Sciences.
ABSTRACT
FASTER is an H2020 research project, within the European framework, in which Urban Search and Rescue (USAR) teams, in addition to other first responders, conduct an on-theground assessment of latest support technologies. These technologies are to be used in victim rescue response situations well as for coordination and safety procedures between disaster responders in diverse types of catastrophe scenarios. The tools have been developed by technical partners of the FASTER project committee and, with the aim of assessing the tools, two pilot exercises were conducted in collapsed buildings in Spain, simulating the impact of two earthquakes. The objective is to integrate and adapt the FASTER tools in initial interventions during the search for and rescue of victims. The focus is placed on information gathering in the disaster area, among other aspects. Simulation exercises were conducted in real locations involving collapsed buildings using drones, unmanned vehicles, canine wearables, a mobile command centre, a weather station and social network analysis, with real people acting the part of victims together with human dummy figures. Through these exercises, an assessment was carried out of the acceptability, ease of use, applicability, efficiency, and effectiveness of FASTER technology. The outbreak of the COVID-19 pandemic during the implementation of various pilot exercises was a setback that led us to introduce a USAR Camp deployment procedure involving preventive anti-COVID-19 measures, in accordance with the recommendations of official organisations such as INSARAG and the WHO. © 2023 by Nova Science Publishers, Inc. All rights reserved.
ABSTRACT
The COVID-19 pandemic and its impact on patients with cancer and cardiovascular disease have confirmed the particular vulnerability of this population. Indeed, not only a higher risk of contracting the infection has been reported, but also an increased occurrence of a more severe course and unfavorable outcome. Beyond the direct consequences of COVID-19, the pandemic has an enormous impact on global health systems. Screening programs and non-urgent tests have been postponed;clinical trials have suffered a setback. Similarly, in the area of cardiology care, a significant decline in ST-elevation myocardial infarction accesses and an increase in cases of late presenting heart attacks with increased mortality and complication rates have been reported. Health care systems must therefore get ready to tackle the "rebound effect" that will likely show a relative increase in the short and medium term incidence of diseases such as heart failure, myocardial infarction, arrhythmias and cardio- and cerebrovascular complications. Scientific societies are taking action to provide general guidance and recommendations aimed at mitigating the unfavorable outcomes of this pandemic emergency. Cardio-oncology, as an emerging discipline, is more flexible in modulating care pathways and represents a beacon of innovation in the development of multi-specialty patient management. In the era of the COVID-19 pandemic, cardio-oncology has rapidly modified its clinical care pathways and implemented flexible monitoring protocols that include targeted use of cardiac imaging, increased use of biomarkers, and telemedicine systems. The goal of these strategic adjustments is to minimize the risk of infection for providers and patients while maintaining standards of care for the treatment of oncologic and cardiovascular diseases. The aim of this position paper is to evaluate the impact of the COVID-19 pandemic on the management of cardio-oncologic patients with the-state-of-the-art knowledge about SARS-CoV-2 and COVID-19 in order to optimize medical strategies during and after the pandemic.